secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spero Therapeutics, Inc. (SPRO)
CIK:        0001701108
Form:       8-K
Filed at:   2024-06-03T23:59:59+00:00
Accession:  0001193125-24-153034
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spero Therapeutics shareholders approve 3M share increase for 2017 stock plan
-----------------------------------------------------------------------------

- Stockholders approved amendment to 2017 Stock Incentive Plan, adding 3,000,000 authorized shares.
- All three Class I director nominees (Scott Jackson, John C. Pottage Jr., Cynthia Smith) were reelected.
- Ratification of PricewaterhouseCoopers as auditor for FY2024 passed with 36.6M votes for.
- Advisory vote on executive compensation approved (23.9M for, 442k against).
- Quorum of 68.23% of outstanding shares present at annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701108/000119312524153034/0001193125-24-153034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701108/000119312524153034/d842476d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-153034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer